|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 47/61 | |
| A61K 47/56 | |||
| A61K 47/54 | |||
| A61K 31/7125 | |||
| A61P 1/16 |
| (11) | Number of the document | 3439703 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17715730.2 |
| Date of filing the European patent application | 2017-04-05 | |
| (97) | Date of publication of the European application | 2019-02-13 |
| (45) | Date of publication and mention of the grant of the patent | 2020-04-29 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2017/058112 |
| Date | 2017-04-05 |
| (87) | Number | WO 2017/174657 |
| Date | 2017-10-12 |
| (30) | Number | Date | Country code |
| 16163939 | 2016-04-05 | EP |
| (72) |
FRAUENDORF, Christian, DE
CAMERON, Mark, DE
|
| (73) |
Silence Therapeutics GmbH,
Robert-Rössle-Strasse 10, 13125 Berlin,
DE
|
| (54) | NUCLEIC ACID LINKED TO A TRIVALENT GLYCOCONJUGATE |
| NUCLEIC ACID LINKED TO A TRIVALENT GLYCOCONJUGATE |